Free Trial

Deltex Medical Group (DEMG) Competitors

GBX 0.04 0.00 (-10.00%)
As of 01/21/2025 11:40 AM Eastern

DEMG vs. SUN, SN, MXCT, NIOX, EKF, CREO, IUG, NCYT, BELL, and POLX

Should you be buying Deltex Medical Group stock or one of its competitors? The main competitors of Deltex Medical Group include Surgical Innovations Group (SUN), Smith & Nephew (SN), MaxCyte (MXCT), NIOX Group (NIOX), EKF Diagnostics (EKF), Creo Medical Group (CREO), Intelligent Ultrasound Group (IUG), Novacyt (NCYT), Belluscura (BELL), and Polarean Imaging (POLX). These companies are all part of the "medical devices" industry.

Deltex Medical Group vs.

Surgical Innovations Group (LON:SUN) and Deltex Medical Group (LON:DEMG) are both small-cap medical companies, but which is the better stock? We will compare the two companies based on the strength of their valuation, earnings, institutional ownership, media sentiment, profitability, dividends, risk, analyst recommendations and community ranking.

25.8% of Surgical Innovations Group shares are held by institutional investors. Comparatively, 18.9% of Deltex Medical Group shares are held by institutional investors. 67.2% of Surgical Innovations Group shares are held by company insiders. Comparatively, 67.7% of Deltex Medical Group shares are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company will outperform the market over the long term.

Surgical Innovations Group received 62 more outperform votes than Deltex Medical Group when rated by MarketBeat users. Likewise, 68.36% of users gave Surgical Innovations Group an outperform vote while only 64.84% of users gave Deltex Medical Group an outperform vote.

CompanyUnderperformOutperform
Surgical Innovations GroupOutperform Votes
121
68.36%
Underperform Votes
56
31.64%
Deltex Medical GroupOutperform Votes
59
64.84%
Underperform Votes
32
35.16%

Surgical Innovations Group has a beta of 0.65, indicating that its share price is 35% less volatile than the S&P 500. Comparatively, Deltex Medical Group has a beta of 0.78, indicating that its share price is 22% less volatile than the S&P 500.

Surgical Innovations Group has higher revenue and earnings than Deltex Medical Group.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Surgical Innovations Group£12.54M0.37N/AN/AN/A
Deltex Medical Group£1.78M0.38-£1.29MN/AN/A

Surgical Innovations Group has a net margin of -4.96% compared to Deltex Medical Group's net margin of -72.49%. Surgical Innovations Group's return on equity of -6.04% beat Deltex Medical Group's return on equity.

Company Net Margins Return on Equity Return on Assets
Surgical Innovations Group-4.96% -6.04% -3.03%
Deltex Medical Group -72.49%-57.02%-7.77%

In the previous week, Deltex Medical Group had 1 more articles in the media than Surgical Innovations Group. MarketBeat recorded 1 mentions for Deltex Medical Group and 0 mentions for Surgical Innovations Group. Surgical Innovations Group's average media sentiment score of 0.67 beat Deltex Medical Group's score of 0.00 indicating that Surgical Innovations Group is being referred to more favorably in the media.

Company Overall Sentiment
Surgical Innovations Group Positive
Deltex Medical Group Neutral

Summary

Surgical Innovations Group beats Deltex Medical Group on 8 of the 13 factors compared between the two stocks.

Get Deltex Medical Group News Delivered to You Automatically

Sign up to receive the latest news and ratings for DEMG and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of LON and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

DEMG vs. The Competition

MetricDeltex Medical GroupMedical Devices IndustryMedical SectorLON Exchange
Market Cap£684,000.00£2.27B£5.39B£2.04B
Dividend Yield2.19%2.37%5.37%5.16%
P/E Ratio-5.75218.1888.831,926.65
Price / Sales0.38206.181,280.48384,006.48
Price / Cash9.0015.3836.6029.21
Price / BookN/A4.394.963.08
Net Income-£1.29M£77.46M£117.89M£183.60M
7 Day PerformanceN/A2.40%1.67%1.24%
1 Month PerformanceN/A11.23%3.62%3.43%
1 Year PerformanceN/A23.94%26.15%43.35%

Deltex Medical Group Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
DEMG
Deltex Medical Group
N/AGBX 0.04
-10.0%
N/A-78.2%£684,000.00£1.78M-5.7537News Coverage
Gap Down
SUN
Surgical Innovations Group
N/AGBX 0.51
-10.8%
N/A-16.2%£4.71M£12.54M-21.1180Gap Up
High Trading Volume
SN
Smith & Nephew
3.6637 of 5 stars
GBX 983.80
-0.4%
GBX 3,916
+298.0%
-6.5%£8.58B£5.64B3,643.7018,452High Trading Volume
MXCT
MaxCyte
N/AGBX 389
+5.7%
N/A-2.1%£408.80M£45.44M-1,496.1580Gap Up
High Trading Volume
NIOX
NIOX Group
N/AGBX 59
-2.0%
N/A+6.7%£250.24M£39M2,950.0092
EKF
EKF Diagnostics
N/AGBX 25.70
flat
N/A-19.9%£116.61M£50.95M2,570.00356Gap Up
CREO
Creo Medical Group
N/AGBX 18
-1.4%
N/A-55.4%£65.12M£30.30M-300.00279News Coverage
IUG
Intelligent Ultrasound Group
N/AGBX 12.75
flat
N/A+40.1%£41.70M£9.88M-1,275.0065
NCYT
Novacyt
N/AGBX 56
-1.6%
N/A-4.4%£39.55M£18.56M-107.69120News Coverage
BELL
Belluscura
N/AGBX 8.95
-0.6%
N/A-52.3%£15.06M£1.80M-89.4524High Trading Volume
POLX
Polarean Imaging
N/AGBX 1.20
-2.0%
N/A-85.2%£14.52M£1.87M-60.0028

Related Companies and Tools


This page (LON:DEMG) was last updated on 1/22/2025 by MarketBeat.com Staff
From Our Partners